Based on ratings from 4 stock analysts, the TG Therapeutics Inc stock price is expected to increase by 122.33% in 12 months. This is calculated by using the average 12-month stock price forecast for TG Therapeutics Inc. The lowest target is $22.00 and the highest is $45.00. Please note analyst price targets are not guaranteed and could be missed completely.
About 4 Wall Street analysts have assignedTGTX 4 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect TG Therapeutics Inc to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on TGTX. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
andrea tan Goldman Sachs | Hold | None | reiterated | Jan 9, 2024 |
corinne jenkins Goldman Sachs | Hold | None | maintained | Nov 1, 2023 |
arlinda lee Canaccord Genuity | Hold | None | rated | Sep 1, 2015 |
In 2023, TGTX generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that TGTX's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
SOFI-USD
$8.33
TMUS-USD
$161.76
TXN-USD
$162.4
UPST-USD
$33.9
$27.88
TXG-USD
$49.11